AMY DUDAS: Open Payments
NPI 1972837540 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,796 in 175 payments from 29 companies in 2025. Trend: 2023 $2,596 · 2024 $2,673 · 2025 $2,796
Food & beverage: $2,786Education: $10
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 59 | $551 |
| Madrigal Pharmaceuticals | 25 | $438 |
| Corcept Therapeutics | 16 | $295 |
| Novo Nordisk Inc | 13 | $259 |
| Tandem Diabetes Care, Inc. | 15 | $196 |
| Medtronic, Inc. | 2 | $158 |
| Lilly USA, LLC | 9 | $128 |
| KYOWA KIRIN, INC. | 3 | $78 |
| Sequel Med Tech, LLC | 1 | $73 |
| CeQur Corporation | 1 | $72 |
Products named: Dexcom G6 Transmitter, REZDIFFRA, Korlym, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, JARDIANCE, DEXCOM G7 GSS (161), MOUNJARO.
Industry payments across PA — which companies pay providers there.
